Abstract
The present study aimed to investigate whether rebamipide, a novel antiulcer agent that has an oxygen radical scavenging activity, would inhibit lipid peroxidation, NF-κB activation, and IL-8 production by H. pylori. Human gastric epithelial cells (AGS and KATO III), treated with rebamipide or not were incubated in the absence or the presence of H. pylori. As a result, H. pylori significantly stimulated IL-8 production, which was similar to time course stimulation of lipid peroxidation. Other cytokines (IL-1α, IL-1β, IL-6, TNF-α) were not stimulated by H. pylori. Treatment with H. pylori resulted in the activation of two species of NF-κB dimers (a p50/p65 heterodimer and a p50 homodimer). Rebamipide significantly inhibited lipid peroxidation as an indicative of oxidative damage, NF-κB complex formation, and IL-8 production by H. pylori. In conclusion, rebamipide may attenuate H. pylori-induced gastric inflammation by inhibiting lipid peroxidation and oxidant-mediated activation of NF-κB and thereby decreasing IL-8 production.
Similar content being viewed by others
REFERENCES
Craig PM, Territo MC, Kames WE, Walsh JH: Helicobacter pylori secretes a chemotactic factor for monocytes and neutrophils. Gut 33:1020-1023, 1992
Grisham DY: Pathogenic mechanisms loading to Helicobacter pylori-induced inflammation. Eur J Gastroenterol Hepatol 4:S9-S16, 1992
Davies GR, Simmonds NJ, Stevens TR, Sheaff MT, Banatvala N, Lauremson IF, Blake DR, Rampton DS: Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 35:179-185, 1994
Bagchi D, Bhattacharya G, Stohs SJ: Production of reactive oxygen species by gastric cells in association with Helicobacter pylori. Free Radic Res 24:439-450, 1996
Zhang Q, Dawodu JB, Etolhi G, Husain A, Gemmell CG, Russell RI: Relationship between the mucosal production of reactive oxygen radicals and density of Helicobacter pylori in patients with duodenal ulcer. Eur J Gastro-Hepatol 9:261-265, 1997
Crabtree JE: Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 10:29-37, 1996
Huang J, Otoole PW, Doig P, Trust TJ: Stimulation of interleukin-8 production in epithelial cell lines by Helicobacter pylori. Infect Immun 63:1732-1738, 1995
Harris PR, Mobley HLT, Perez-Perez GI, Blaser MJ, Smith PD: Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 111:419-425, 1996
Peek RM, Miller GG, Tham KT, Perez-Perez GI, Zhao X, Atherton JC, Blaser MJ: Heightened inflammatory response and cytokine expression in vivo to cag A+ Helicobacter pylori strains. Lab Invest 71:760-770, 1995
Yamaoka Y, Kita M, Kodama T, Sawai N, Imanishi J: Helicobacter pylori cag A gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 110:1744-1752, 1996
Zhang Y, Broser M, Rom WN: Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factor NF-IL6 and NF-κB. Proc Natl Acad Sci USA 91:2225-2229, 1994
Beg AA, Finco TS, Nantermet PV, Baldwin AS: Tumor necrosis factor and interleukin-1 lead to phosphorylation of IkBa: A mechanism for NF-κB activation. Mol Cell Biol 13:3301-3310, 1993
Libermann TA, Baltimore D: Activation of interleukin-6 gene expression through NF-κB transcription factor. Mol Cell Biol 10:2327-2334, 1990
Parikh AA, Salzman AL, Kane CD, Fischer JE, Hasselgren PO: IL-6 production in human intestinal epithelial cells following stimulation with IL-1b is associated with activation of the transcription factor NF-κB. J Surg Res 69:139-144, 1997
Keates S, Hitti YS, Upton M, Kelly CP: Helicobacter pylori infection activates NF-κB in gastric epithelial cells. Gastroenterology 113:1099-1109, 1997
Aihara M, Azuma A, Takizawa H, Tsuchimoto D, Funakoshi Y, Shindo Y, Ohmoto Y, Imagawa K, Kikuchi M, Mukaida N, Matsushima K: Molecular analysis of suppression of interleukin-8 production by rebamipide in Helicobacter pylori-stimulated gastric cancer cell lines. Dig Dis Sci 43:174S-180S, 1998
Matsusaka TK, Fujikawa Y, Nishio N, Mukaida K, Matsushima T, Kishimoto S, Akira S: Transcription factors NF-IL-6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proc Nat Acad Sci USA 90:10193-10197, 1993
Mukaida N, Mahe Y, Matsushima K: Cooperative interaction of nuclear factor-κB and cis-regulatory enhancer binding protein-like factor in activating the interleukin-8 gene by proinflammatory cytokines. J Biol Chem 265:21128-21133, 1990
Mukaida N, Okamoto S, Ishikawa Y, Matsushima K: Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol 56:554-558, 1994
Meyer M, Schreck R, Baeuerle PA: Hydrogen peroxide and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J 12:2005-20015, 1993
Schenk H, Klein M, Erdbrugger W, Droge W, Schulze-Osthoff K: Distint effects of thioredoxin and antioxidants on the activation of transcription factors NF-κB and AP-1. Proc Natl Acad Sci USA 91:1672-1676, 1994
Tanaka C, Kamata H, Takeshita H, Yagisawa H, Hirata H: Redox regulation of lipopolysaccharide-induced interleukin-8 gene expression mediated by NF-κB and AP-1 in human astrocytoma U373 cells. Biochem Biophys Res Commun 232:568-573, 1997
Munoz C, Pascual-Salcedo D, Castellanos MC, Alfranca A, Aragoves J, Vara A, Redondo MJ, de Landazuri MO: Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: modulation of NF-kappa B and AP-1 transcription factors activity. Blood 88:3482-3490, 1996
Ziegler-Heitbrock HW, Sternsdorf T, Liese J, Belohradsky B, Weber C, Wedel A, Schreck R, Bauerle P, Strobel M: Pyrrolidine dithiocarbamate inhibits NF-kappa B mobilization and TNF production in human monocytes. J Immunol 151:6986-6993, 1993
Naito Y, Yoshikawa T, Tanigawa T, Sakurai K, Yamasaki K, Uchida M, Kondo M: Hydroxyl radical scavenging by rebamipide and related compounds: Electron paramagnetic resonance study. Free Radic Biol Med 18:117-123, 1995
Ogino K, Hobara T, Ishiyama H, Yamasaki K, Kobayashi H, Izumi Y, Oka S: Antiulcer mechanism of action of rebamipide, a novel antiulcer compound, on diethyl dithiocarbamate-induced antral gastric ulcers in rats. Eur J Pharmacol 212:9-13, 1992
Kim CD, Hong KW: Preventive effect of rebamipide on gastric lesions induced by ischemia-reperfusion in the rat. J Pharmacol Exp Ther 275:340-344, 1995
Yoshida N, Yoshikawa T, Iinuma S, Arai M, Takenaka S, Sakamoto K, Miyajima T, Nakamura Y, Yagi N, Naito Y, Mukai F, Kondo M: Rebamipide protects against activation of neutrophils by Helicobacter pylori. Dig Dis Sci 4:1139-1144, 1996
Suzuki M, Miura S, Mori M, Kai A, Suzuki H, Fukumura D, Suematsu M, Tsuchiya M: Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants. Gut 35:1375-1378, 1994
Aihara M, Tsuchimoto D, Takizawa H, Azuma A, Wakebe H, Ohmoto Y, Imagawa K, Kikudi M, Mukaida N, Matsushima K: Mechanisms involved in Helicobacter pylori-induced interleukin-8 production by a gastric cancer cell line, MKN45. Infect Immun 65:3218-3224, 1997
Yagi KA: Simple fluorometric assay for lipoperoxide in blood plasma. Biochem Med 15:212-216, 1976
Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489, 1983
Zar BH: Biostatistical Analysis. Englewood Cliffs, NJ, Prentice-Hall, 1984
Thanos D, Maniatis T: NF-kappa B: A lesson in family values. Cell 80:529-532, 1995
Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K: Tumor necrosis factor a and interferon g synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-κB-like binding sites of the interleukin 8 gene. J Biol Chem 267:22506-22511, 1992
DeForge LE, Preston AM, Takeuchi E, Kenney J, Boxer LA, Remick DG: Regulation of interleukin 8 gene expression by oxidant stress. J Biol Chem 268:25568-25576, 1993
Ishihara K, Komuro Y, Nishiyama N, Yamasaki K, Hotta K: Effect of rebamipide on mucus secretion by endogenous prostaglandin-independent mechanism in rat gastric mucosa. Arzneimittelforschung 42:1462-1466, 1992
Yamasaki K, Kanbe T, Chijiwa T, Ishiyama H, Moritas T: Gastric mucosal protection by OPC-12759, a novel antiulcer compound, in the rat. Eur J Pharmacol 142:23-29, 1987
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, H., Seo, J.Y. & Kim, K.H. Inhibition of Lipid Peroxidation, NF-κB Activation and IL-8 Production by Rebamipide in Helicobacter pylori-Stimulated Gastric Epithelial Cells. Dig Dis Sci 45, 621–628 (2000). https://doi.org/10.1023/A:1005474013988
Issue Date:
DOI: https://doi.org/10.1023/A:1005474013988